Strategy for lamivudine-resistant YMDD mutant-associated chronic hepatitis B

Journal of Gastroenterology

Volumn 36, Issue 2, 2001, Pages 139-141

  Kiyosawa, K ^a   Tanaka, E ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis B; Interferon therapy; Lamivudine; YMDD mutant

Indexed keywords

ACICLOVIR; ADEFOVIR; ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE; ASPARTIC ACID; BETA INTERFERON; HEPATITIS B(E) ANTIGEN; IMMUNOMODULATING AGENT; INTERFERON; ISOLEUCINE; LAMIVUDINE; LOBUCAVIR; METHIONINE; NUCLEOSIDE ANALOG; PLACEBO; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE; TYROSINE; VALINE; VIDARABINE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

AMINO ACID SUBSTITUTION; CHRONIC HEPATITIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG APPROVAL; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOMODULATION; JAPAN; LIVER CELL; LONG TERM CARE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; SIDE EFFECT; TREATMENT PLANNING; VIRUS INHIBITION; VIRUS MUTATION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; DRUG RESISTANCE, MICROBIAL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MUTATION; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0035077078     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350170145     Document Type: Editorial

References (16)

1. Therapeutic effect of a low dosage of human leucocyte interferon on chronic hepatitis B virus infection
2. The treatment of chronic hepatitis
3. Inhibition of the replication of hepatitis B virus in vivo by 2′,3′-dideoxy-3′-thiocytidine and related analogues
4. Biochemical pharmacology of (+)- and (-)-2′,3′-dideoxy-3′-thiocytidine as anti-hepatitis B virus agents
5. Phosphatidyl-2′,3′-dideoxy-3′-thiocytidine: Synthesis and activity in hepatitis B and HIV-1-infected cells
6. A preliminary trial of lamivudine for chronic hepatitis B infection
7. A 1-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study
8. Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation
9. Characterization of the antiviral effects of 2′-carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus
10. Anti-HIV and anti-HBV activity and resistance profile of 2′-3′-dideoxy-3′-thiocyanate (3TC) and its arylphosphoramidate derivative CF 1109
11. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine
12. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
13. Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant
14. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy
15. Lamivudine and intron A combination treatment in patients with chronic hepatitis B infection
16. Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors